Masterclass: Mastering Next Generation Stimulant Formulations and Delivery Systems for Individualized Patient Care Across the Lifespan in ADHD

Accurate ADHD diagnosis and individualized treatment require an understanding of diverse symptom presentations, developmental stages, gender differences, and common psychiatric comorbidities. This masterclass will explore evidence-based diagnostic approaches and the pharmacology, clinical evidence, and practical distinctions among next-generation stimulant formulations, including prodrugs, evening-dosed extended-release options, and transdermal delivery systems. Faculty will discuss how age, comorbidities, adherence patterns, and dosing flexibility inform treatment selection across the lifespan. Through shared decision-making strategies, participants will learn to align treatment with each patient’s needs, preferences, and functional goals.

Supported by an educational grant from Collegium Pharmaceutical.